Surgical Sealants and Adhesives Market Size, Share & Trends Analysis Report By Product, By Indication (Surgical Hemostasis, Tissue Sealing, Tissue Engineering) By Application, By Region, And Segment Forecasts, 2024-2031
The Global Surgical Sealants and Adhesives Market Size is valued at 2.87 Billion in 2023 and is predicted to reach 6.26 Billion by the year 2031 at a 10.39 % CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The increased frequency and incidences of various health disorders and ailments globally are greatly responsible for the growth of this market.
- The increasing number of chronic health conditions is expected to drive industry growth.
- North America dominated the market and accounted for a revenue share of global revenue in 2023.
- One of the significant concerns restraining industry growth is the huge costs incurred by the surgical process and the availability of alternatives to surgical devices.

Surgical adhesives and sealants are substances with natural or synthetic origins that are added to sutures in order to prevent infection, repair damaged tissue boundaries, and speed healing. Given their capacity to reduce blood loss, enhance closure, and enable less painful and easier operations without the need for removal, these materials are emerging as potential substitutes for staples and sutures in many medical applications. The market for surgical sealants and adhesives is anticipated to expand as chronic health conditions like cardiovascular disease, kidney illness, neurological problems, and others are becoming more common. Another reason boosting the market for surgical sealants and adhesives is the rise in car accidents requiring urgent procedures.
Market Segmentation:
The surgical sealants and adhesives market is divided into product, indication, and application. Based on product, the market is segmented into Natural/Biological Sealants and Adhesives and Synthetic and Semi-synthetic Sealants and Adhesives. Based on indication, the surgical sealants and adhesives market is segmented into Surgical Hemostasis, Tissue Sealing, Tissue Engineering. Based on application, the market is bifurcated and divided into General Surgeries, Cardiovascular Surgeries, Central Nervous System Surgeries, Orthopedic Surgeries, Urological Surgeries, and Others.
Based on product, the biological segment is a major contributor to the surgical sealants and adhesives market.
The market's leading segment is the biological segment. Fibrin, collagen, and gelatin-based sealants and adhesives are further categories for natural or biological materials because of the many medical settings in which they are used. They are useful in thoracic, cardiovascular, orthopedic, neuro, and reconstructive operations. Additionally, only fibrin and other sealants have FDA permission for usage in all three categories, namely hemostats, sealants, and adhesives.
The central nervous system (CNS) segment witnessed growth at a rapid rate.
The central nervous system (CNS) category had the highest revenue share since CNS illnesses are quite common worldwide. In CNS procedures, sealants are preferred to conventional closure techniques, including wires, sutures, and staples. Because traditional sealant techniques are challenging to use in CNS surgeries, there is an exponentially growing need for surgical sealants and adhesives for CNS.
North America holds a significant regional revenue share.
The North American region market is expected to register the highest market share. This is majorly due to some elements, including the prevalence of chronic health conditions, an increase in age-related health problems, essential businesses engaged in manufacturing surgical sealants and adhesives, cutting-edge medical facilities, etc. One of the key elements fueling the growth of the North American surgical sealants and adhesives market is the increased frequency of chronic conditions needing surgery, notably in the United States. Besides, the Asia Pacific region is estimated to hold the largest share of the market. The aging population is propelling the surgical sealants and adhesives market, which is more likely to experience health issues, including heart disease, bone disease, eye problems, and others that call for immediate surgery.
Competitive Landscape
Some major key players in the Global Surgical Sealants and Adhesives Market:
- Bard,
- Johnson & Johnson (UK),
- Baxter International,
- Medtronic plc (US),
- Braun Melsungen AG (Germany),
- Cohera Medical,
- Sanofi Group (France),
- Sealantis,
- Vivostat A/S (Denmark),
- Ocular Therapeutics
Global Surgical Sealants and Adhesives Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 2.87 Billion |
| Revenue Forecast In 2031 | USD 6.26 Billion |
| Growth Rate CAGR | CAGR of 10.39% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Billion and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Product, Indication, Application |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | R. Bard, Johnson & Johnson (UK), Baxter International, Medtronic plc (US), Braun Melsungen AG (Germany), Cohera Medical, Sanofi Group (France), Sealantis, Vivostat A/S (Denmark), Ocular Therapuetix |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Surgical Sealants and Adhesives Market
By Product
- Natural/Biological Sealants and Adhesives
- Natural/Biological Sealants and Adhesives, By Type
- Polypeptide/Protein-based Sealants and Adhesives
- Fibrin Based
- Gelatin Based
- Collagen Based
- Albumin Based
- Polysaccharide-based Sealants and Adhesives
- Chitosan Based
- Others
- Natural/Biological Sealants and Adhesives, by Origin
- Human Blood Based
- Animal Based
- Synthetic and Semi-synthetic Sealants and Adhesives
- Cyanoacrylates
- Polyethylene glycol Based Hydrogels
- Urethane Based
- Others
- Polypeptide/Protein-based Sealants and Adhesives
- Natural/Biological Sealants and Adhesives, By Type
By Indication
- Surgical Hemostasis
- Tissue Sealing
- Tissue Engineering
By Application
- General Surgeries
- Cardiovascular Surgeries
- Central Nervous System Surgeries
- Orthopedic Surgeries
- Urological Surgeries
- Others
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
The Global Surgical Sealants and Adhesives Market Size is valued at 2.87 Billion in 2023 and is predicted to reach 6.26 Billion by the year 2031
The Global Surgical Sealants and Adhesives Market is expected to grow at a 10.39 % CAGR during the forecast period for 2024-2031.
R. Bard, Johnson & Johnson (UK), Baxter International, Medtronic plc (US), Braun Melsungen AG (Germany), Cohera Medical, Sanofi Group (France), Sealan